Literature DB >> 8506479

Group A streptococcal bacteremia in a mid-south children's hospital.

R J Leggiadro1, M C Bugnitz, B A Peck, G S Luedtke, M H Kim, E L Kaplan, P M Schlievert.   

Abstract

We reviewed microbiology and infection control records at a Memphis children's hospital from 1982 to 1990 to obtain epidemiologic, clinical, and microbiologic data on group A streptococcal (GAS) bacteremia. Varicella was the underlying condition in 8 of 37 (22%) patients identified and was often associated with severe GAS disease, including toxic shock-like syndrome. Twenty-one of 31 (68%) available blood isolates made GAS pyrogenic exotoxin (SPE) B by Ouchterlony immunodiffusion; gene probes identified speC and speA in 18 (58%) and 8 (26%) isolates, respectively. The B/C toxin profile, identified in 11 (35%) isolates, was the most common profile in this population, and the overall rate for speC was higher than rates recently reported from other areas. Although the clinical significance of the toxin profiles in our population is unclear, these data emphasize the geographic and temporal variability in the microbiologic properties of GAS disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8506479     DOI: 10.1097/00007611-199306000-00004

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals.

Authors:  P M Schlievert; L M Jablonski; M Roggiani; I Sadler; S Callantine; D T Mitchell; D H Ohlendorf; G A Bohach
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

2.  Potentially lethal bacterial infection associated with varicella zoster virus.

Authors:  A J Pollard; A Isaacs; E G Hermione Lyall; N Curtis; K Lee; S Walters; M Levin
Journal:  BMJ       Date:  1996-08-03

3.  Superantigenicity of helper T-cell mitogen (SPM-2) isolated from culture supernatants of Streptococcus pyogenes.

Authors:  H Rikiishi; S Okamoto; S Sugawara; K Tamura; Z X Liu; K Kumagai
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.